Cyanotech (CYAN) Stock Price

Cyanotech Price

NASDAQ·CLOSED
0.57
​
Market closed

Over the last 19 years Cyanotech grew revenue by 5.5% annually, reaching 26.59 M USD. Earnings per share have grown at 3.8% per year over the last 13 years. For Cyanotech, the net margin of -4.8% is down versus 6.0% a few years ago.

Cyanotech stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cyanotech business model & stock analysis

Cyanotech Corp. engages in the development and commercialization of natural products derived from microalgae. The company is headquartered in Kailua Kona, Hawaii and currently employs 88 full-time employees. The firm's products include Hawaiian Spirulina Pacifica and Hawaiian BioAstin. Hawaiian Spirulina Pacifica is a dietary supplement used for extra energy, a strengthened immune system, cardiovascular benefits and as a source of antioxidant carotenoids. Hawaiian BioAstin is a dietary antioxidant shown to support and maintain the body's natural inflammatory response, to enhance skin, and to support eye and joint health. The firm cultivates over two microalgal species from which its product lines, natural astaxanthin products and spirulina products, are derived. The firm produces its algae in Hawaii and manufactures the finished products in Hawaii and California.

Frequently asked questions about Cyanotech

Converted at the current exchange rate, the Cyanotech share trades at 0.51 EUR (0.57 USD).

The Cyanotech share (CYAN) is listed on 2 stock exchanges, including: NASDAQ (CYAN), Frankfurt (JC7A.F).

The revenue of Cyanotech is 26.59 M USD. This figure is based on current financial data and reflects the company's business performance.

The profit of Cyanotech is -1.28 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Cyanotech is currently -3.23. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Cyanotech stock.

The price-to-sales ratio (P/S) of Cyanotech is currently 0.16. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Cyanotech stock.

The Eulerpool Quality Score for Cyanotech is 1/10.

The ISIN of Cyanotech is US2324374006. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Cyanotech is A0LEA5. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Cyanotech is CYAN. The ticker symbol is used to trade Cyanotech shares on the stock exchange.

Fair ValueTerminal
0.48 USD
Over-/UndervaluationTerminal
Fairly valued
Industry
Personal Products
Number of shares
Employees
Revenue per Employee
320,325.30 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Currency
USD
Initial public offering
May 21, 1999
ISIN
US2324374006
Cusip
232437301
Sedol
B1GK6Z7
Market capitalization
4.03 M USDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
0.53
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-6.66 %
Last updated Oct 31, 2026, 10:58 AM

All fundamentals and in-depth analysis of Cyanotech

Our stock analysis for Cyanotech stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cyanotech. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.